A phase 2 trial of frexalimab, a cd40l antagonist, in adolescents and adults with recent‐onset type 1 diabetes (FABULINUS): rationale and study design
Cherkas A, Rotthaeuser B, Porksen N, et al.
Diabetes Obes Metab. Pub. online 27 May 2026.
Leggi
Cherkas A, Rotthaeuser B, Porksen N, et al.
Diabetes Obes Metab. Pub. online 27 May 2026.
Leggi
Marzano F, Paolillo S, Gargiulo P, et al.
Cardiovasc Diabetol. Pub. online 25 May 2026.
Leggi
Pantazopoulos D, Gouveri E, Papazoglou D, Papanas N
Diabetes Res Clin Pract. Pub. online 27 May 2026.
Leggi
Pillay D, Paul N, Harrison A, et al.
Diabetologia. Pub. online 26 May 2026.
Leggi
21 May 2026
Leggi
Wiegman A, Bourbon M, Freiberger T, et al.
Eur Heart J. Pub. online 25 May 2026.
Leggi
Donovan LE, Lemieux P, Yamamoto JM, et al.
Diabetes Care. Pub. online 27 May 2026.
Leggi
Bech AA, Kvist AV, Vestergaard P, Rasmussen NH
Diabetes Care. Pub. online 27 May 2026.
Leggi
Herranz-Antolín S, Gómez-Peralta F, Yongjin X, et al.
Diabetes Technol Ther. Pub. online 28 May 2026.
Leggi
Kataoka Y, Ray KK, Nicholls SJ, et al.
Eur Heart J. Pub. online 24 May 2026.
Leggi